Moberg Pharma’s transfers of own shares completed
STOCKHOLM, June 28th, 2019 – As previously disclosed, the Board of Directors of Moberg Pharma AB (publ) (“Moberg Pharma”) has resolved, pursuant to the authorization granted by the Annual General Meeting held on May 15th, 2019, to transfer not more than 45,000 of the company’s own ordinary shares on Nasdaq Stockholm. The purpose of the transfers is to cover certain costs, mainly social security costs, that may arise in relation to implemented incentive programs.The transfers of all shares needed to cover the costs that arises in relation to exercised warrants and allotted shares in